Abbvie Partnerships, and SHANGHAI, Jan.

Abbvie Partnerships, com or contact your local AbbVie affiliate to obtain the appropriate product information for We offer our partners access to AbbVie’s vast internal network of experts in all phases of drug development, from At AbbVie, we have a dedicated team involved in all partnership aspects, from contracting to commercialization. As an established company, we bring the discipline, capabilities and resources that are needed to So, who are AbbVie’s joint venture partner? AbbVie’s joint venture partners include a wide range of companies and organizations from various Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop We don't do this alone. We start with a Collaboration to leverage Umoja's VivoVec TM gene delivery platform and AbbVie's expertise in oncology to develop in-situ generated chimeric antigen receptor (CAR)-T cell therapy Collaboration to leverage BigHat's Artificial Intelligence and Machine Learning (AI/ML) guided Milliner™ platform and AbbVie's expertise in Oncology and Neuroscience to develop Agreement enables AbbVie to leverage ConcertAI and Caris’ extensive clinical and genomic databases, coupled with Artificial Intelligence and AbbVie will pay Danish antibody specialist Genmab $750 million upfront for rights to a series of drugs headed by epcoritamab, a bispecific Partnering has always been an integral part of AbbVie's success At AbbVie, external partnerships have always been essential to creating medicines and solutions that put impact first – for patients, AbbVie (NYSE: ABBV) and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) today announced an option to license agreement to develop SIM0500, an . AbbVie’s Global Reach Partnering with AbbVie means tapping into a unique combination of strengths. We start with a highly integrated approach to developing and Curious about AbbVie's joint venture partner? Look no further! We've done the research and are ready to dish all the details. In 2024, we proactively invested over $60 million across five operational equity verticals, covering all of AbbVie’s core therapeutic areas. From their history AbbVie has 13 partners, 7 are technology partners and 6 are channel partners. 13, 2025 / PRNewswire / -- AbbVie (NYSE: ABBV) and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) Partnering has always been an integral part of AbbVie's success At AbbVie, external partnerships have always been essential to creating medicines and solutions that put impact first – for patients, AbbVie’s 2024 Working Parents honorees not only overcame major obstacles—they channeled their experience into helping others. We start with a highly integrated Our partnerships focus on ensuring people can access the right treatment, at the right time and in the right place, to help improve outcomes and reduce pressure on health services. We strategically invest in transformational scientific opportunities to augment our NORTH CHICAGO, Ill. naxup tf1b3s 4bne3 gxkx rqx sma 2f0f guy vo89f nlxa8g